Haoxi Health locks in $4M registered direct offering at $0.40/share, layering on pre-funded warrants
HAO is trading near its 52-week low of $0.248 (4.3% above the low) on elevated volume (2.0× avg).
Summary
Haoxi Health Technology finalizes a $4 million registered direct offering at $0.40 per share with 9.7 million pre-funded warrants, securing critical capital but imposing massive dilution risk on existing shareholders.
Key Events · Financing and Capital Events · HAO
-
$4M Registered Direct Offering Priced at $0.40/Share
Haoxi Health is selling 300,000 Class A Ordinary Shares at $0.40 per share and 9,700,000 pre-funded warrants (exercise price $0.33) for gross proceeds of up to $4 million. The offering price represents a premium to the current market price of $0.2581, but the warrants create a massive overhang.
-
Extreme Dilution from Pre-Funded Warrants
Should all 9.7 million pre-funded warrants be exercised, total outstanding Class A Ordinary Shares would balloon from 1.9 million to 11.9 million, diluting existing shareholders by over 80%. The warrants are exercisable immediately and carry no expiration.
-
Net Proceeds of ~$3.59 Million for Working Capital
After placement agent fees (7.0% of gross proceeds plus 0.5% expense reimbursement and up to $60,000 in expenses), net proceeds are estimated at approximately $3.59 million. The funds will be directed to general corporate purposes, including operating expenses and business development.
-
90-Day Lock-Up for Insiders
Directors, officers, and 5%+ shareholders have agreed to a 90-day lock-up period post-closing, restricting sales of additional shares. This offers some short-term protection against immediate insider selling.
Analysis · HAO · Trade & Services
Haoxi Health Technology is raising $4 million through a registered direct offering, selling 300,000 Class A Ordinary Shares at $0.40 each alongside 9,700,000 pre-funded warrants exercisable at $0.33. While the offering price sits at a premium to the current market price of $0.2581, the massive overhang from the warrants—potentially 9.7 million additional shares—creates extreme dilution risk. Net proceeds of approximately $3.59 million provide critical working capital for a company that has been burning cash and recently executed a 128-for-1 reverse split to maintain its Nasdaq listing. The offering follows a series of dilutive capital raises and shareholder approvals for astronomical authorized share increases, signaling ongoing financial distress. Trading near its 52-week low, the stock will face further pressure from this deal, necessary as it is for survival.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HAO was trading at $0.26 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $573.6K. The 52-week trading range was $0.25 to $285.44. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.